Regulation of angiogenesis by hypoxia: role of the HIF system
The DOI matches its Crossref record, with a small difference in title or year; 121 of the 121 references it cites were found in a registry or an index.
Abstract
The regulation of angiogenesis by hypoxia is an important component of homeostatic mechanisms that link vascular oxygen supply to metabolic demand. Molecular characterization of angiogenic pathways, identification of hypoxia-inducible factor (HIF) as a key transcriptional regulator of these molecules, and the definition of the HIF hydoxylases as a family of dioxygenases that regulate HIF in accordance with oxygen availability have provided new insights into this process. Here we review these findings, and the role of HIF in developmental, adaptive and neoplastic angiogenesis. We also discuss the implications of oncogenic activation of extensive, physiologically interconnected hypoxia pathways for the tumor phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Self-citation
Cited by
Items 301–400 of 1,008
Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
Ghosh, A. K., Shanafelt, T. D., Cimmino, A., Taccioli, C., Volinia, S., Liu, C.-G., Calin, G. A., Croce, C. M., Chan, D. A., Giaccia, A. J., et al. (2009) · Blood · doi:10.1182/blood-2008-10-185686 · Cited by 137
Hypoxia-Induced Endothelial Proliferation Requires Both mTORC1 and mTORC2
Li, W., Petrimpol, M., Molle, K. D., Hall, M. N., Battegay, E. J., & Humar, R. (2007) · Circulation Research · doi:10.1161/01.res.0000253094.03023.3f · Cited by 137
Conditional HIF-1α Expression Produces a Reversible Cardiomyopathy
Bekeredjian, R., Walton, C. B., MacCannell, K. A., Ecker, J., Kruse, F., Outten, J. T., Sutcliffe, D., Gerard, R. D., Bruick, R. K., & Shohet, R. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011693 · Cited by 136
Hu, Q., Zhu, Y., Mei, J., Liu, Y. L., & Zhou, G. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01717-y · Cited by 181
Vallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 150
Sanjuán-Pla, A., Cervera, A. M., Apostolova, N., Garcia-Bou, R., Víctor, V. M., Murphy, M. P., & McCreath, K. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.088 · Cited by 135
Couvelard, A., O’Toole, D., Leek, R., Turley, H., Sauvanet, A., Degott, C., Ruszniewski, P. B., Belghiti, J., Harris, A. L., Gatter, K. C., et al. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02160.x · Cited by 144
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis
Jung, C., Hwang, K., Yoo, J., Cho, W.-K., Kim, J., Kim, W. H., & Im, D. (2006) · Nature Medicine · doi:10.1038/nm1440 · Cited by 155
Doege, K., Heine, S., Jensen, I., Jelkmann, W., & Metzen, E. (2005) · Blood · doi:10.1182/blood-2005-03-1138 · Cited by 128
Neurovascular Congruence during Cerebral Cortical Development
Stubbs, D., DeProto, J., Nie, K., Englund, C., Mahmud, I., Hevner, R., & Molnár, Z. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp040 · Cited by 133
The Role of PDGFs and PDGFRs in Colorectal Cancer
Manzat Saplacan, R. M., Balacescu, L., Gherman, C., Chira, R. I., Craiu, A., Mircea, P. A., Lisencu, C., & Balacescu, O. (2017) · Mediators of Inflammation · doi:10.1155/2017/4708076 · Cited by 133
Centanin, L., Dekanty, A., Romero, N. M., Irisarri, M., Gorr, T. A., & Wappner, P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.020 · Cited by 150
Physiologic Angiodynamics in the Brain
Dore-Duffy, P., & La Manna, J. C. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1713 · Cited by 132
Kuang, R., Zhang, Z., Jin, X., Hu, J., Shi, S., Ni, L., & Ma, P. X. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.01.032 · Cited by 141
Renal hypoxia in kidney disease: Cause or consequence?
Ow, C. P. C., Ngo, J. P., Ullah, M. M., Hilliard, L. M., & Evans, R. G. (2017) · Acta Physiologica · doi:10.1111/apha.12999 · Cited by 139
Ao, A., Wang, H., Kamarajugadda, S., & Lu, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711677105 · Cited by 131
Activation of Cancer Cell Migration and Invasion by Ectopic Synthesis of Coagulation Factor VII
Koizume, S., Jin, M.-S., Miyagi, E., Hirahara, F., Nakamura, Y., Piao, J., Asai, A., Yoshida, A., Tsuchiya, E., Ruf, W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1803 · Cited by 133
Khaliq, A. M., Rajamohan, M., Saeed, O. A. M., Mansouri, K., Adil, A., Zhang, C., Turk, A. A., Carstens, J. L., House, M. G., Hayat, S., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01914-4 · Cited by 160
Visualization of Hypoxia in Microscopic Tumors by Immunofluorescent Microscopy
Li, X.-F., Carlin, S., Urano, M., Russell, J., Ling, C. C., & O'Donoghue, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4353 · Cited by 130
Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis
Lee, S.-J., Kim, H.-P., Jin, Y., Choi, A. M. K., & Ryter, S. W. (2011) · Autophagy · doi:10.4161/auto.7.8.15598 · Cited by 129
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
Gawlik-Rzemieniewska, N., & Bednarek, I. A. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1121348 · Cited by 148
Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis
Yao, M., Jiang, Q., Ma, Y., Liu, C., Zhu, C.-Y., Sun, Y., Shan, K. Y., Ge, H., Zhang, Q., Zhang, H., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.022 · Cited by 137
Wang, M., Kirk, J. S., Venkataraman, S., Domann, F. E., Zhang, H. J., Schafer, F. Q., Flanagan, S. W., Weydert, C. J. D., Spitz, D. R., Buettner, G. R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208986 · Cited by 141
SAKAI, T., Sameshima, T., Matsufuji, M., Kawamura, N., Dobashi, K., & Mizui, Y. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.173 · Cited by 131
Zhang, Q., Lou, Y., Zhang, J., Fu, Q., Wei, T., Sun, X., Chen, Q., Yang, J., Bai, X., & Liang, T. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0689-5 · Cited by 128
Dzobo, K., Senthebane, D. A., Ganz, C., Thomford, N. E., Wonkam, A., & Dandara, C. (2020) · Cells · doi:10.3390/cells9081896 · Cited by 127
Uemura, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25964 · Cited by 128
Hypoxia‐inducible factors in stem cells and cancer
Mazumdar, J., Dondeti, V., & Simon, M. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00963.x · Cited by 126
Linehan, W. M., & Zbar, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.006 · Cited by 129
Tumor Angiogenesis: Cause or Consequence of Cancer?
Shchors, K., & Evan, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2053 · Cited by 127
Hayden, M. R., & Tyagi, S. C. (2004) · Cardiovascular Diabetology · doi:10.1186/1475-2840-3-1 · Cited by 147
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Stegen, S., Stockmans, I., Moermans, K., Thienpont, B., Maxwell, P. H., Carmeliet, P., & Carmeliet, G. (2018) · Nature Communications · doi:10.1038/s41467-018-04679-7 · Cited by 126
Iwasaki, M., Zhao, H., Jaffer, T., Unwith, S., Benzonana, L. L., Lian, Q., Sakamoto, A., & Ma, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8304 · Cited by 129
Ryu, D., Yu, M. R., Kong, K. H., Kim, H., Kwon, S., Jeon, J. S., Han, D. C., & Noh, H. (2019) · Aging Cell · doi:10.1111/acel.12904 · Cited by 139
A review of accelerated wound healing approaches: biomaterial- assisted tissue remodeling
Nour, S., Baheiraei, N., Imani, R., Khodaei, M., Alizadeh, A., Rabiee, N., & Moazzeni, S. M. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6319-6 · Cited by 144
Nitric oxide and superoxide: Interference with hypoxic signaling
BRUNE, B., & ZHOU, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.03.005 · Cited by 125
Wang, X.-L., Xu, R., Wu, X., Gillespie, D. L., Jensen, R. L., & Lu, Z. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800192d · Cited by 133
Hypoxia and Metabolic Factors That Influence Inflammatory Bowel Disease Pathogenesis
Glover, L. E., & Colgan, S. P. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.056 · Cited by 124
Full range physiological mass transport control in 3D tissue cultures
Hsu, Y.-H., Moya, M. L., Abiri, P., Hughes, C. C. W., George, S. C., & Lee, A. P. (2013) · Lab Chip · doi:10.1039/c2lc40787f · Cited by 124
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog
Nwabo, K. A. H., Takam, K. P., Tagne, S. R., Vecchio, L., Seke, E. P. F., Muller, J. M., Bassi, G., Lukong, E., Kumar, G. R., Mbo, A. J., et al. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0032 · Cited by 124
Differential activation of vascular genes by hypoxia in primary endothelial cells
Nilsson, I., Shibuya, M., & Wennström, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.005 · Cited by 132
Hypoxia-inducible factor 1 (HIF-1) in cancer
Quintero, M., Mackenzie, N., & Brennan, P. A. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.03.008 · Cited by 139
Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis
Lee, J. J., Natsuizaka, M., Ohashi, S., Wong, G. S., Takaoka, M., Michaylira, C. Z., Budo, D., Tobias, J. W., Kanai, M., Shirakawa, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp326 · Cited by 130
Kwon, H., Jeon, W. K., Hwang, J., Lee, C., So, J., Park, J., Ko, B., & Im, S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.015 · Cited by 134
Bartonella spp.: Throwing light on uncommon human infections
Kaiser, P. O., Rieß, T., O’Rourke, F., Linke, D., & Kempf, V. A. J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.06.004 · Cited by 125
Song, N., Huang, Y., Shi, H., Yuan, S., Ding, Y., Song, X., Fu, Y., & Luo, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2007 · Cited by 122
Regulation and role of endogenously produced hydrogen sulfide in angiogenesis
Katsouda, A., Bibli, S., Pyriochou, A., Szabó, C., & Papapetropoulos, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.026 · Cited by 128
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
Prolyl 4‐hydroxylases, master regulators of the hypoxia response
Myllyharju, J. (2013) · Acta Physiologica · doi:10.1111/apha.12096 · Cited by 134
A mathematical model of ischemic cutaneous wounds
Xue, C., Friedman, A., & Sen, C. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909115106 · Cited by 131
Expression of hypoxia-inducible transcription factors in developing human and rat kidneys
Bernhardt, W. M., Schmitt, R., Rosenberger, C., Münchenhagen, P., Gröne, H., Frei, U. A., Warnecke, C., Bachmann, S., Wiesener, M. S., Willam, C., et al. (2005) · Kidney International · doi:10.1038/sj.ki.5000062 · Cited by 136
Leukocyte driven-decidual angiogenesis in early pregnancy
Lima, P. D. A., Zhang, J., Dunk, C., Lye, S. J., & Croy, B. A. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.63 · Cited by 127
Real-Time Imaging of HIF-1α Stabilization and Degradation
Moroz, E., Carlin, S., Dyomina, K., Burke, S., Thaler, H. T., Blasberg, R., & Serganova, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005077 · Cited by 118
Wilkins, H. M., Harris, J. L., Carl, S. M., E, L., Lu, J., Eva Selfridge, J., Roy, N., Hutfles, L., Koppel, S., Morris, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu371 · Cited by 118
Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
Lin, Z., Zhang, Q., & Luo, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.039 · Cited by 126
Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
Wen, Y., Zhou, X., Lu, M., He, M., Tian, Y., Liu, L., Wang, M., Tan, W., Deng, Y., Yang, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0552-1 · Cited by 129
Delayed Arteriogenesis in Hypercholesterolemic Mice
Tîrziu, D., Moodie, K. L., Zhuang, Z. W., Singer, K., Helisch, A., Dunn, J. F., Li, W., Singh, J., & Simons, M. (2005) · Circulation · doi:10.1161/circulationaha.105.542829 · Cited by 121
Hypoxia-induced methylation of a pontin chromatin remodeling factor
Lee, J. S., Kim, Y., Bhin, J., Shin, H.-J. R., Nam, H. J., Lee, S. H., Yoon, J.-B., Binda, O., Gozani, O., Hwang, D., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106106108 · Cited by 115
The role of hypoxia‐inducible factor‐2 alpha in angiogenesis
Befani, C. D., & Liakos, P. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26805 · Cited by 139
The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression
To, K. K. W., Sedelnikova, O. A., Samons, M., Bonner, W. M., & Huang, E. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601369 · Cited by 143
The Met pathway: master switch and drug target in cancer progression
Mazzone, M., & Comoglio, P. M. (2006) · The FASEB Journal · doi:10.1096/fj.06-5947rev · Cited by 124
Zou, J., Peng, L., Lu, F., Liu, N., Dai, J., Ye, J., Qu, X., Sun, X., Ma, D., Park, J., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-3 · Cited by 121
Chang, Y., Yang, C., Lin, M., Wu, C., & Yang, P. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.03.012 · Cited by 126
Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa- β
Al‐Malki, A. L., & Sayed, A. A. R. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-282 · Cited by 116
Melatonin modulates the expression of VEGF and HIF‐1α induced by CoCl2 in cultured cancer cells
Dai, M., Cui, P., Yu, M., Han, J., Li, H., & Xiu, R. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00498.x · Cited by 128
Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity
An, J., & Rettig, M. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7546-7556.2005 · Cited by 116
Hou, Z.-J., Nie, C., Si, Z., & Ma, Y. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.04.012 · Cited by 123
Current Understanding of the Molecular Biology of Pancreatic Neuroendocrine Tumors
Zhang, J., Francois, R. A., Iyer, R. V., Seshadri, M., Zajac‐Kaye, M., & Hochwald, S. N. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt135 · Cited by 123
Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications
Tarnawski, A. S., & Jones, M. K. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0479-y · Cited by 125
Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway
Hu, L., Zang, M., Wang, H., Li, J., Su, L., Yan, M., Li, C., Yang, Q., Liu, B., & Zhu, Z. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.08.002 · Cited by 125
Verseijden, F., Sluijs, S. J. P.-V., Pavljasevic, P., Hofer, S. O. P., van Osch, G. J. V. M., & Farrell, E. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0106 · Cited by 128
Schweighofer, B., Testori, J., Sturtzel, C., Sattler, S., Mayer, H., Wagner, O., Bilban, M., & Hofer, E. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0830 · Cited by 114
MicroRNAs as pharmacological targets in endothelial cell function and dysfunction
Chamorro-Jorganes, A., Araldi, E., & Suárez, Y. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.002 · Cited by 122
Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumors
Pluemsampant, S., Safronova, O. S., Nakahama, K., & Morita, I. (2007) · International Journal of Cancer · doi:10.1002/ijc.23094 · Cited by 125
Pajusola, K., Künnapuu, J., Vuorikoski, S., Soronen, J., André, H., Pereira, T., Korpisalo, P., Ylä‐Herttuala, S., Poellinger, L., & Alitalo, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-3720fje · Cited by 114
Hypoxia-regulated lncRNAs in cancer
Chang, Y., Zhang, K., Hu, Z., Qi, H.-X., Shi, Z., Han, X., Han, Y., & Wei, H. (2015) · Gene · doi:10.1016/j.gene.2015.08.049 · Cited by 118
Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy
Pedrón, S., & Harley, B. A. C. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34637 · Cited by 127
WNT signaling – lung cancer is no exception
Rapp, J., Járomi, L., Kvell, K., Miskei, G., & Pongracz, J. E. (2017) · Respiratory Research · doi:10.1186/s12931-017-0650-6 · Cited by 120
Seeliger, H., Guba, M. O., Kleespies, A., Jauch, K., & Bruns, C. J. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9077-8 · Cited by 120
Critchley, H. O. D., Osei, J., Henderson, T. A., Boswell, L., Sales, K. J., Jabbour, H. N., & Hirani, N. (2006) · Endocrinology · doi:10.1210/en.2005-1153 · Cited by 113
Zhang, X., Lam, K. S. L., Ye, H., Chung, S. K., Zhou, M., Wang, Y., & Xu, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135509 · Cited by 112
Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
Paternostro, C., David, E., Novo, E., & Parola, M. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i3.281 · Cited by 128
MicroRNAs in endothelial cell homeostasis and vascular disease
Fernandez-Hernando, C. F., & Suárez, Y. (2018) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000424 · Cited by 118
Hanlon, M. M., Rakovich, T. Y., Cunningham, C. C., Ansboro, S., Veale, D. J., Fearon, U., & McGarry, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02056 · Cited by 122
Hypoxia-inducible factors and hypoxic cell death in tumour physiology
Bacon, A., & Harris, A. (2004) · Annals of Medicine · doi:10.1080/07853890410018231 · Cited by 112
Wei, M. Q., Ellem, K. A. O., Dunn, P., West, M., Bai, C. X., & Vogelstein, B. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.005 · Cited by 123
Botting, K. J., McMillen, I. C., Forbes, H., Nyengaard, J. R., & Morrison, J. L. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000531 · Cited by 111
Nour, S., Imani, R., Chaudhry, G. R., & Sharifi, A. M. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37105 · Cited by 125
Willam, C., Maxwell, P. H., Nichols, L., Lygate, C. A., Tian, Y., Bernhardt, W. M., Wiesener, M. S., Ratcliffe, P. J., Eckardt, K., & Pugh, C. W. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.04.009 · Cited by 129
Self-citationAngiogenesis: a curse or cure?
Gupta, K., & Zhang, J. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.023309 · Cited by 114
Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice
Zhao, M., Tang, S., Marsh, J. L., Shankar, S., & Srivastava, R. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.009 · Cited by 119
Ji, X., Wang, H., Zhu, J., Zhu, L., Pan, H., Li, W., Zhou, Y., Cong, Z., Yan, F., & Chen, S. (2014) · International Journal of Cancer · doi:10.1002/ijc.28699 · Cited by 110
Nangaku, M., Izuhara, Y., Takizawa, S., Yamashita, T., Fujii-Kuriyama, Y., Ohneda, O., Yamamoto, M., van Ypersele de Strihou, C., Hirayama, N., & Miyata, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.148551 · Cited by 110
Lactate administration reproduces specific brain and liver exercise‐related changes
E, L., Lu, J., Selfridge, J. E., Burns, J. M., & Swerdlow, R. H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12394 · Cited by 109
Vhlh Gene Deletion Induces Hif-1-Mediated Cell Death in Thymocytes
Biju, M. P., Neumann, A. K., Bensinger, S. J., Johnson, R. S., Turka, L. A., & Haase, V. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9038-9047.2004 · Cited by 110
Tong, Y., Zhang, X., Tian, F., Yi, Y., Xu, Q.-Z., Li, L., Tong, L., Lin, L., & Ding, J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20804 · Cited by 109
Interaction of the TAZ1 Domain of the CREB-Binding Protein with the Activation Domain of CITED2
De Guzman, R. N., Martinez-Yamout, M. A., Dyson, H. J., & Wright, P. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310348200 · Cited by 108
Oskolkova, O. V., Afonyushkin, T., Leitner, A., von Schlieffen, E., Gargalovic, P. S., Lusis, A. J., Binder, B. R., & Bochkov, V. N. (2008) · Blood · doi:10.1182/blood-2007-09-112870 · Cited by 108
van Rooijen, E., Voest, E. E., Logister, I., Bussmann, J., Korving, J., van Eeden, F. J., Giles, R. H., & Schulte‐Merker, S. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004036 · Cited by 110
Does iron have a role in breast cancer?
Huang, X. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70200-6 · Cited by 108
Metadata
- Authors
- Pugh, C. W., & Ratcliffe, P. J.
- Corresponding author
- Ratcliffe, Peter J
- Venue
- Nature Medicine
- Published
- 2003-06
- Volume
- 9
- Issue
- 6
- Pages
- 677-684
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2013818100
- Cited by
- 2,520
- References
- 121
- Citations by year
- 2026: 42 · 2025: 70 · 2024: 98 · 2023: 106 · 2022: 111 · 2021: 106 · 2020: 108 · 2019: 117 · 2018: 91 · 2017: 118 · 2016: 110 · 2015: 116 · 2014: 130 · 2013: 138 · 2012: 121
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- angiogenesis, hypoxia, hypoxia-inducible factor, dioxygenase, oxygen sensing, transcriptional regulation, developmental angiogenesis, tumor angiogenesis, tumor phenotype
- MeSH terms
- Animals, Hypoxia, DNA-Binding Proteins, Humans, Hydroxylation, Neoplasms, Neovascularization, Pathologic, Nuclear Proteins, Transcription Factors, Gene Expression Regulation, Developmental, Neovascularization, Physiologic, Protein Isoforms, Protein Subunits, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.